The HHS proposal to eliminate prescription drug rebates in Medicare Part D will not lead to increased premiums and government spending despite some projections to the contrary, US HHS Secretary Alex Azar assured the Senate Finance Committee at a March 14 hearing.
The hearing focused on the President’s budget proposal for 2020
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?